Condition: Glioblastoma Multiforme · Glioblastoma · Sponsor: University of Florida
This is a phase I study to assess the safety and feasibility of IL-8 receptor modified patient-derived activated CD70 CAR T cell therapy in CD70+ adult glioblastoma
This description comes directly from the study's public registry record.
Phuong Deleyrolle, RN · 352-273-5519 · wells-BTC@ufl.edu
Marcia Hodik, RN · 352-273-5519 · wells-BTC@ufl.edu
Always discuss trial participation with your own doctor first.
| University of Florida Health | Gainesville, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05353530